Identify the genetic basis of myopathies
Subgroup Leader : Valérie BIANCALANA
We study rare and severe neuromuscular disorders caused by mutations in proteins controlling intracellular organization and dynamics. We aim to tackle the three main bottlenecks in this field:
.jpg)
Identify the genetic basis of myopathies, myalgia and high athletic performances
Project leaders : Valérie BIANCALANA, Johann BOHM, Jocelyn LAPORTE
Understand and cure myotubular/centronuclear myopathies through gene modulation and pharmacology
Project leader : Jocelyn LAPORTE
Understand and cure tubular aggregates myopathy and Stormorken syndrome through gene modulation and pharmacology
Project leader : Johann BOHM
Subgroup Leader : Valérie BIANCALANA
Subgroup Leader : Jocelyn LAPORTE
Article in a journal
Cell Reports ; Volume: 11 ; Page: 1564-1576
Article in a journal
Revue Neurologique ; Volume: 171 ; Page: 558-571
Article in a journal
Genetics and Molecular Biology ; Volume: 38 ; Page: 147 - 151
Article in a journal
PeerJ ; Volume: 3 ; Page: e796
Article in a journal
Journal of Cell Biology ; Volume: 210 ; Page: 833--849
Article in a journal
Journal of Neuromuscular Diseases ; Volume: 2 ; Page: 193-203
Article in a journal
European Journal of Human Genetics ; Volume: 23 ; Page: 417-425
Article in a journal
Brain - A Journal of Neurology ; Volume: 137 ; Page: 3160-3170
Article in a journal
Nature Communications ; Volume: 5 ; Page: 5647
Article in a journal
Journal of Medical Genetics ; Volume: 51 ; Page: 824-833
Current fundings:

Her work, supervised by Dr. Jocelyn Laporte, is entitled "New Therapeutic Approaches for Neuromuscular Diseases."
Read more
Follow our publications and latest research on Researchgate : www.researchgate.net/profile/Jocelyn-Laporte
Raw data for our study on Multi-omics comparisons of different forms of centronuclear myopathies and the effects of several therapeutic strategies. Mol Ther. 2021 Apr 30:S1525-0016(21)00247-1.
www.ncbi.nlm.nih.gov/geo/query/acc.cgi
www.sciencedirect.com/science/article/abs/pii/S1525001621002471
In the press: